The recording of the CE portion of this webinar will ONLY be available
to conference attendees via the ODAC 2022 Onsite App.
If you would like to view the recording, please register for ODAC above.
*Please Note: The non-CE sponsored workshop will not be recorded.
In order to claim CE for the ODAC 2022 Pre-Conference Symposium,
you must be registered as a ODAC 2022 conference attendee.
Instructions on how to claim CE for the Pre-Conference Symposium will be provided on the ODAC 2022 Onsite App. If you would like to register for ODAC 2022, please click the register button above.
*Please Note: The sponsored workshop is non-CE.
Pre-Conference Symposium – Tuesday (11/16): 1.75 hours
Live Conference Dates – Friday (1/14): 8.0 hours; Saturday (1/15): 6.0 hours; Sunday (1/16): 6.75 hours; Monday (1/17): 3.75 hours
Total – 26.25 hours
Creighton University Health Sciences Continuing Education designates this live activity for a maximum of 26.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.
Creighton University Health Sciences Continuing Education designates this activity for 26.25 contact hour(s) for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Creighton University Health Sciences Continuing Education (HSCE) and the Physicians Continuing Education Corporation. Creighton University Health Sciences Continuing Education (HSCE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This continuing education activity is supported by independent medical education grants provided by:
Galderma, L.P, Merz North America, Sanofi Genzyme and Regeneron Pharmaceuticals
Grant Research Support – Pfizer
Consultant – L’Oreal, La Roche-Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Sonoma Pharmaceuticals, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Corbus Therapeutics, Hoth Therapeutics
Speakers’ Bureau – Regeneron, Dermira, Janssen, AbbVie
Major Stockholder – Zylo
Grant/Research Support – BMS, Leo, UCB, Lilly, Dermavant, Dermira, Pfizer
Consultant – AbbVie, Almirall, Arcutis, ASLAN, BI, BMS, EPI, Leo, Incyte, UCB, Janssen, Lilly, Nimbus, Novartis, Ortho, Sun, Dermavant, Dermira, Sanofi, Regeneron, Parexel, Pfizer, Modmed
Nothing to disclose
Grant/Research Support – Pfizer
Consultant – Janssen, Unilever
Other Financial or Materials Support – Advisory Boards for Novartis, UCB, Lilly, Pfizer
Grant/Resrearch Support – Galderma
Consultant – AbbVie, Afyx, Aobiome, Arena, Asana, BioMX, Boehringer-Ingelheim, Celgene, Dermavant, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Leo Pharma, Novartis, Pfizer, RAPT, Regeneron, Sanofi-Genzynme
Speakers’ Bureau – AbbVie, Elil Lilly, Leo Pharma, Pfizer, Regeneron, Sanofi-Genzyme